Search Prime Contracts

75N93023C00029

Definitive Contract

Overview

Government Description
IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE STERILIZATION AND PRODUCE AN INSTRUMENT DESIGNED WITH PORTABILITY AND RAPID INSTALLATION IN LOW RESOURCE ENVIRONMENTS. TH
Awardee
Redbud Labs
Awarding / Funding Agency
National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN41 - Health R&D Services; Health Care - Other; Basic Research
Place of Performance
Durham, NC 27709 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Related Opportunity
None
Analysis Notes
Amendment Since initial award the Potential End Date has been shortened from 09/14/26 to 09/14/25.
Redbud Labs was awarded Definitive Contract 75N93023C00029 (75N930-23-C-00029) worth up to $1,799,353 by the National Institute of Allergy and Infectious Diseases in September 2023. The contract has a duration of 2 years and was awarded with a Small Business Total set aside with NAICS 541715 and PSC AN41 via direct negotiation acquisition procedures with 3 bids received.

SBIR Details

Research Type
Small Business Innovation Research Program (SBIR) Phase I
Title
IMPLEMENT EXTRACTION COMPATIBILITY WITH WHOLE BLOOD AND TISSUE LYSATES WITH INDUSTRY ACCEPTABLE BIOSAFETY STANDARDS THAT INCLUDE STERILIZATION AND PRODUCE AN INSTRUMENT DESIGNED WITH PORTABILITY AND R
Abstract
To advance the capacity for sample processing and pathogen discovery in the field to improve downstream diagnostic applications.
Research Objective
The goal of phase I is to establish the technical merit, feasibility, and commercial potential of proposed R&D efforts and determine the quality of performance of the small business awardee organization.
Topic Code
120
Agency Tracking Number
75N93023C00029
Solicitation Number
PHS-2023-1
Contact
Richard Spero

Status
(Complete)

Last Modified 3/26/25
Period of Performance
9/15/23
Start Date
9/14/25
Current End Date
9/14/25
Potential End Date
100% Complete

Obligations
$1.8M
Total Obligated
$1.8M
Current Award
$1.8M
Potential Award
100% Funded

Award Hierarchy

Definitive Contract

75N93023C00029

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75N93023C00029

Labor Services Billing

Annual labor billing rates and FTE reported for 75N93023C00029

Year Services Invoiced Hours FTE Blended Rate
2023 $220,000 1,642.0 0.8 $133.98
2024 $958,000 6,279.8 3.0 $152.55

Transaction History

Modifications to 75N93023C00029

People

Suggested agency contacts for 75N93023C00029

Competition

Number of Bidders
3
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
KJGXVMFV9U14
Awardee CAGE
66CA6
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhssujeong
Last Modified By
hhsbmadgey
Approved By
hhsbmadgey

Legislative

Legislative Mandates
None Applicable
Performance District
NC-04
Senators
Thom Tillis
Ted Budd
Representative
Valerie Foushee

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) Health research and training Research and development contracts (25.5) $1,799,353 100%
Modified: 3/26/25